-
Fate Therapeutics, Inc. (NASDAQ:FATE) Director Acquires $668,579.52 in Stock
ソース: Buzz FX / 26 12 2024 22:16:13 America/New_York
Fate Therapeutics, Inc. (NASDAQ:FATE) Director Acquires $668,579.52 in Stock Written by MarketBeat December 26, 2024 Share Link copied to clipboard. Fate Therapeutics, Inc. ( NASDAQ:FATE - Get Free Report ) Director Redmile Group, Llc acqui
Read more...